-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 HzGGZ7fU3P0e8aoRnuqWppCtvcJ/fxjazW6pDnMFbu8Fiq53DW3a+GmCinSKh9x/
 9+OoyjVWvJoHS3Z/kRL7tA==

<SEC-DOCUMENT>0000069499-03-000053.txt : 20030822
<SEC-HEADER>0000069499-03-000053.hdr.sgml : 20030822
<ACCEPTANCE-DATETIME>20030822163939
ACCESSION NUMBER:		0000069499-03-000053
CONFORMED SUBMISSION TYPE:	4/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20030822
FILED AS OF DATE:		20030822

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			BORKOWSKI EDWARD
		CENTRAL INDEX KEY:			0001197542

	FILING VALUES:
		FORM TYPE:		4/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-09114
		FILM NUMBER:		03862930

	MAIL ADDRESS:	
		STREET 1:		MYLAN PHARMACEUTICALS INC
		STREET 2:		781 CHESTNUT RIDGE RD
		CITY:			MORGANTOWN
		STATE:			WV
		ZIP:			26505

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MYLAN LABORATORIES INC
		CENTRAL INDEX KEY:			0000069499
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				251211621
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			0331

	BUSINESS ADDRESS:	
		STREET 1:		1500 CORPORATE DRIVE
		STREET 2:		SUITE 400
		CITY:			CANONSBURG
		STATE:			PA
		ZIP:			15317
		BUSINESS PHONE:		724-514-1800

	MAIL ADDRESS:	
		STREET 1:		1500 CORPORATE DRIVE
		STREET 2:		SUITE 400
		CITY:			CANONSBURG
		STATE:			PA
		ZIP:			15317

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FRM CORP
		DATE OF NAME CHANGE:	19711003
</SEC-HEADER>
<DOCUMENT>
<TYPE>4/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>

<ownershipDocument>

    <schemaVersion>X0201</schemaVersion>

    <documentType>4/A</documentType>

    <periodOfReport>2003-08-22</periodOfReport>

    <dateOfOriginalSubmission>2003-08-22</dateOfOriginalSubmission>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0000069499</issuerCik>
        <issuerName>MYLAN LABORATORIES INC</issuerName>
        <issuerTradingSymbol>MYL</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001197542</rptOwnerCik>
            <rptOwnerName>BORKOWSKI EDWARD</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>MYLAN PHARMACEUTICALS INC</rptOwnerStreet1>
            <rptOwnerStreet2>781 CHESTNUT RIDGE RD</rptOwnerStreet2>
            <rptOwnerCity>MORGANTOWN</rptOwnerCity>
            <rptOwnerState>WV</rptOwnerState>
            <rptOwnerZipCode>26505</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Chief Financial Officer</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>

        <nonDerivativeTransaction>
            <securityTitle>
                <value>Mylan Laboratories Inc. Common Stock</value>
                <footnoteId id="F1"/>
            </securityTitle>
            <transactionDate>
                <value>2003-08-22</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>30000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>30000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>

    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">The Reporting Person was granted restricted stock pursuant to the Mylan Laboratories Inc. 2003 Long-Term Incentive Plan. The shares vest on August 21, 2006 (previously inadvertently reported as 2005). Mylan Laboratories Inc. common stock Indirect ownership through 401(k) holdings was 327 shares as of August 21, 2003.</footnote>
    </footnotes>


    <ownerSignature>
        <signatureName>Edward J. Borkowski</signatureName>
        <signatureDate>2003-08-22</signatureDate>
    </ownerSignature>

</ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----